MedTrace Logo

Clinical Trials

NCT06241300 | RECRUITING | NA
180 participants

Executive Function and Parenting in Childhood

Study Type:
INTERVENTIONAL
Last Updated:
2026-07-09
Start Date:
2023-11-20
Completion:
2028-02-28
Conditions
  • Disruptive Behavior Disorder, Childhood Onset
  • Disruptive Behavior
  • Executive Function
Interventions
  • BEHAVIORAL
No Results Yet
NCT06236802 | ACTIVE_NOT_RECRUITING | NA
40 participants

ProVIDE II Bridging Study

Study Type:
INTERVENTIONAL
Last Updated:
2026-07-09
Start Date:
2024-03-06
Completion:
2024-09-06
Conditions
  • BPH With Symptomatic Lower Urinary Tract Symptoms
Interventions
  • DEVICE
No Results Yet
NCT06120231 | RECRUITING | NA
50 participants

Pulse-Width Modulation

Study Type:
INTERVENTIONAL
Last Updated:
2026-07-09
Start Date:
2023-12-01
Completion:
2026-06-01
Conditions
  • Spinal Fusion
  • Spinal Stenosis
Interventions
  • DIAGNOSTIC_TEST
No Results Yet
NCT06073132 | ACTIVE_NOT_RECRUITING | PHASE2/PHASE3
80 participants

An International, Multicenter, Randomized, Double-Blind, Parallel Group, Vehicle-Controlled, Phase 2/3 Study With Open-Label Extension Evaluating the Efficacy and Safety of Diacerein 1% Ointment for the Treatment of Generalized Epidermolysis Bullosa Simplex (EBS)

Study Type:
INTERVENTIONAL
Last Updated:
2026-07-09
Start Date:
2024-04-04
Completion:
2026-06-10
Conditions
  • Generalized Epidermolysis Bullosa Simplex
Interventions
  • DRUG
No Results Yet
NCT06015880 | RECRUITING | PHASE1
30 participants

Testing the Combination of Anti-cancer Drugs Mosunetuzumab, Polatuzumab Vedotin, and Lenalidomide for the Treatment of Relapsed/Refractory Diffuse Large B-Cell Lymphoma

Study Type:
INTERVENTIONAL
Last Updated:
2026-07-09
Start Date:
2024-05-20
Completion:
2027-06-30
Conditions
  • Diffuse Large B-Cell Lymphoma, Not Otherwise Specified
  • High Grade B-Cell Lymphoma
  • Transformed Indolent B-Cell Non-Hodgkin Lymphoma to Diffuse Large B-Cell Lymphoma
Interventions
  • PROCEDURE
  • DRUG
  • BIOLOGICAL
No Results Yet
NCT05950464 | RECRUITING | PHASE1
65 participants

Testing Different Amounts of the Combination of Drugs M1774 and ZEN-3694 for the Treatment of Recurrent Ovarian and Endometrial Cancer

Study Type:
INTERVENTIONAL
Last Updated:
2026-07-09
Start Date:
2023-12-18
Completion:
2027-06-30
Conditions
  • Recurrent Endometrial Carcinoma
  • Recurrent Endometrial Clear Cell Adenocarcinoma
  • Recurrent Endometrial Endometrioid Adenocarcinoma
  • Recurrent Endometrial Low Grade Endometrioid Adenocarcinoma
  • Recurrent Ovarian Clear Cell Adenocarcinoma
  • Recurrent Ovarian Endometrioid Adenocarcinoma
  • Recurrent Ovarian High Grade Serous Adenocarcinoma
  • Recurrent Ovarian Low Grade Endometrioid Adenocarcinoma
  • Recurrent Platinum-Resistant Ovarian Carcinoma
Interventions
  • DRUG
  • PROCEDURE
No Results Yet
NCT05935488 | COMPLETED
1 participants

Early Liver Disease Breath Detection

Study Type:
OBSERVATIONAL
Last Updated:
2026-07-09
Start Date:
2024-05-21
Completion:
2024-12-12
Conditions
  • Liver Fibrosis
  • NASH
  • Liver Diseases
Interventions
  • OTHER
No Results Yet
NCT05873686 | RECRUITING | PHASE1
140 participants

A Phase 1 Clinical Study of NXP900 in Subjects With Advanced Cancers

Study Type:
INTERVENTIONAL
Last Updated:
2026-07-09
Start Date:
2023-10-26
Completion:
2027-03-31
Conditions
  • Advanced Solid Tumor
  • NSCLC (Non-small Cell Lung Cancer)
  • Renal Cancer
  • Mesothelioma
  • Non-Small Cell Squamous Lung Cancer
  • Non-small Cell Lung Adenocarcinoma
Interventions
  • DRUG
No Results Yet
Previous
Sorted by latest updates
Next
Showing 40 trials per page